Original Research
Published on 05 Feb 2024
Concomitant inhibition of PI3K/mTOR signaling pathways boosts antiproliferative effects of lanreotide in bronchopulmonary neuroendocrine tumor cells
in Pharmacology of Anti-Cancer Drugs
- 1,452 views
Original Research
Published on 05 Feb 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 05 Feb 2024
in Pharmacology of Anti-Cancer Drugs
Review
Published on 05 Feb 2024
in Pharmacology of Anti-Cancer Drugs
Systematic Review
Published on 05 Feb 2024
in Pharmacology of Anti-Cancer Drugs
Review
Published on 05 Feb 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 02 Feb 2024
in Pharmacology of Anti-Cancer Drugs
Review
Published on 02 Feb 2024
in Pharmacology of Anti-Cancer Drugs
Clinical Trial
Published on 01 Feb 2024
in Pharmacology of Anti-Cancer Drugs
Case Report
Published on 01 Feb 2024
in Pharmacology of Anti-Cancer Drugs
Review
Published on 01 Feb 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 01 Feb 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 31 Jan 2024
in Pharmacology of Anti-Cancer Drugs
Review
Published on 31 Jan 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 29 Jan 2024
in Pharmacology of Anti-Cancer Drugs
Review
Published on 25 Jan 2024
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 25 Jan 2024
in Pharmacology of Anti-Cancer Drugs